CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Methylnaltrexonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01368562
NCT01368562N/ACompleted
CompareCT.gov

A Compassionate Use Study of Methylnaltrexone in Patients With Opioid-Induced Side Effects

Bausch Health Americas, Inc.·interventional·Posted Jun 8, 2011·Updated Sep 4, 2019

In Brief

A clinical study evaluating Methylnaltrexone for Opioid-induced Constipation. Completed, enrolled 26 participants across 1 site.

Detailed Summary

This is an open label compassionate use study of subcutaneously administered methylnaltrexone (MNTX) in participants with advance medical illness and opioid-induced constipation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-induced Constipation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 8, 2011
Enrollment StartJan 24, 2003
Primary CompletionJun 2, 2008
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 15.1 years ago

Interventions

Methylnaltrexonedrug

Methylnaltrexone will be administered as per the dose and schedule specified in the arm.